Tin tức & Cập nhật

Preconception HBV history linked to congenital heart disease risk in offspring
Preconception HBV history linked to congenital heart disease risk in offspring
04 May 2023

Children born to mothers who had contracted hepatitis B virus (HBV) infection before pregnancy appear to be at increased risk of congenital heart diseases (CHDs), as reported in a study.

Preconception HBV history linked to congenital heart disease risk in offspring
04 May 2023
Older IBD patients at disadvantage for medications, surgery
Older IBD patients at disadvantage for medications, surgery
29 Apr 2023

Older patients with inflammatory bowel disease (IBD) are less likely to be initiated on medications and are often scheduled for surgeries, a study has found.

Older IBD patients at disadvantage for medications, surgery
29 Apr 2023
Elective sigmoid resection wards off recurrent diverticulitis, enhance quality of life
Elective sigmoid resection wards off recurrent diverticulitis, enhance quality of life
26 Apr 2023

For patients with recurrent, complicated, or persistent painful diverticulitis, elective sigmoid resection appears to prevent recurrence as well as improve quality of life (QOL) within 2 years as compared with conservative treatment, according to the results of an open-label trial.

Elective sigmoid resection wards off recurrent diverticulitis, enhance quality of life
26 Apr 2023
Patients at risk for BE worried over EAC but rarely undergoes screening: study
Patients at risk for BE worried over EAC but rarely undergoes screening: study
25 Apr 2023

Patients who are prone to Barrett’s esophagus (BE), specifically those belonging to racial and ethnic minorities, express concern about developing esophageal adenocarcinoma (EAC), reveals a study. However, they seldom go through screening and lack awareness of screening recommendations.

Patients at risk for BE worried over EAC but rarely undergoes screening: study
25 Apr 2023
Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection
Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection
23 Apr 2023

Ten-day treatment with vonoprazan 20 mg twice/day plus amoxicillin 750 mg four times/day (VHA-dual) as a first-line therapy for Helicobacter pylori infection results in satisfactory eradication rate of >90 percent, fewer adverse events (AEs), and similar adherence when compared with bismuth quadruple therapy (B-quadruple), results of a study have shown.

Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection
23 Apr 2023
COVID-19 survivors at high risk of subsequent IBS
COVID-19 survivors at high risk of subsequent IBS
21 Apr 2023

Individuals who have contracted COVID-19 at increased risk of developing irritable bowel syndrome (IBS) compared with those who have not been infected, as reported in a study.

COVID-19 survivors at high risk of subsequent IBS
21 Apr 2023